Operating CF
$13.3B
Capex
-$1.4B
Free Cash Flow
$11.9B
FCF Margin
+89.5%
Cash flow waterfall for Bristol-Myers Squibb (BMY) — TTM through Q1 2026
Free cash flow: $11.9B
Cash flow breakdown for Bristol-Myers Squibb (BMY) — TTM through Q1 2026
| Line item | Amount | Running total |
|---|---|---|
| Operating Cash Flow | $13.3B | $13.3B |
| Capital Expenditure | -$1.4B | $11.9B |
| Free Cash Flow | $11.9B | $11.9B |
| Acquisitions | -$3.9B | $8.01B |
| Other Investing | $1.53B | $9.54B |
| Dividends Paid | -$5.07B | $4.47B |
| Net Debt Change | -$5.72B | -$1.25B |
| Other Financing & FX | -$42M | -$1.29B |
| Net Cash Decrease | -$1.29B | -$1.29B |
- Operating Cash Flow$13.3B
- Capital Expenditure-$1.4B
- Free Cash Flow$11.9B
- Acquisitions-$3.9B
- Other Investing$1.53B
- Dividends Paid-$5.07B
- Net Debt Change-$5.72B
- Other Financing & FX-$42M
- Net Cash Decrease-$1.29B
Want to see what drove the FCF change?Free Cash Flow Bridge
Frequently asked questions
Data & methodology
Bristol-Myers Squibb (BMY) Key Financials
Charts, filings, and peer comparison for every metric
Income Statement
Balance Sheet
Cash Flow
Forecast & Valuation
Operations
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
Overview
Income Statement
Capital Return
- Buybacks0.08% TTM
- Dividend Profile4.13% yield
- Dividend Calculator
- Dividend Forecast
- Dividend Capture
- Stock Split History6 splits
How this company returns cash to shareholders — buybacks, dividends, and stock splits.